Raymond Thertulien, MD, PhD, on How Abnormalities Drive Treatment Choices in Multiple Myeloma
Testing for cytogenetic abnormalities is an important step in determining the best course of action when a patient presents with multiple myeloma, Raymond Thertulien, MD, PhD, hematologist-oncologist and director of the myeloma and plasma cell disorders …